RET and thyroid tumor: The fifth edition of the WHO Classification of Thyroid Tumors incorporates key genetic alterations (i.e., BRAF V600E, RAS mutations, RET/PTC rearrangements, and PAX8–PPARG fusions) into the diagnostic framework for follicular-derived neoplasms [76].